Sign In
Buy UL
$59.25
+1.55 (+2.69%)
At Close: Jun 23, 2026
Unilever shares drag as FTSE 100 makes post-pandemic high
09:30am, Monday, 17'th Jan 2022 FXStreet
On watch: Firstly to geopolitics for a change. The situation regards Ukraine and Russia looks precarious. Increasingly this antebellum escalation has
Unilever yet to demonstrate it would be the right owner of GSK's Consumer Healthcare division
09:24am, Monday, 17'th Jan 2022
Has there ever been a time in the last 50 years when investors and Unilever PLC (LSE:ULVR) management alike were not concerned about sluggish growth? With brands such as (deep breath) Hellmann's, Vase
GlaxoSmithKline shares rise after it rejects Unilever bid for its consumer healthcare division
03:50am, Monday, 17'th Jan 2022
GlaxoSmithKline PLC (LSE:GSK) said the £50bn offer by Unilever PLC (LSE:ULVR) for its Consumer Healthcare business fundamentally undervalues the business. Unilever made three unsolicited approaches t
Unilever PLC (LSE:ULVR) has confirmed that it had a bid for GlaxoSmithKline's consumer healthcare business rebuffed. GlaxoSmithKline PLC (LSE:GSK) (GSK) revealed yesterday that it knocked back three a
Unilever says GSK consumer arm 'strong strategic fit' for business
02:55am, Monday, 17'th Jan 2022
(Reuters) -Dove soap maker Unilever signalled on Monday it would pursue a deal for GlaxoSmithKline's consumer health business, calling it a "strong strategic fit" after its 50-billion-pound approach (
Unilever to weigh raising offer for GlaxoSmithKlines consumer division
11:36pm, Sunday, 16'th Jan 2022 Seeking Alpha
Unilever Plc (UL) has negotiated with banks about securing additional financing for a sweetened offer for the consumer unit of GlaxoSmithKline (GSK), Bloomberg reported on Sunday,
GlaxoSmithKline, Unilever Spar Over Future of GSK's Consumer Health Business
11:10pm, Sunday, 16'th Jan 2022
GlaxoSmithKline and Pfizer will hold out for a better bid of at least £60 billion for their joint consumer healthcare venture, in opposition to an earlier offer they didn't like, Financial Times writ
Unilever to weigh raising offer for Glaxo Consumer unit Bloomberg
08:43pm, Sunday, 16'th Jan 2022 FX Empire
(Reuters) Unilever Plc has held talks with banks about additional financing for a potential sweetened offer for GlaxoSmithKline Plcs consumer products division, Bloomberg reported on Sunday, citing people familiar with the matter.
Analysts say GSK is right to rebuff £50bn offer for consumer healthcare venture
07:12pm, Sunday, 16'th Jan 2022 The Guardian
Unilevers offer represents only a modest premium to its current value, according to some leading analysts
GSK banks on stronger offer for its consumer healthcare business
05:17pm, Sunday, 16'th Jan 2022 The Guardian
Analysis: drugmaker appears to be holding out for what would be one of largest ever deals in London after rejecting Unilever bids
Unilever to weigh raising offer for Glaxo Consumer unit - Bloomberg
03:37pm, Sunday, 16'th Jan 2022
Unilever Plc has held talks with banks about additional financing for a potential sweetened offer for GlaxoSmithKline Plc's consumer products division, Bloomberg reported on Sunday, citing people fami
Unilever makes approach for Glaxos consumer-healthcare business
12:06pm, Sunday, 16'th Jan 2022 Livemint
Company says toothpaste-to-painkiller unit would be strong strategic fit
GSK Spurns $68.4B Bid From Unilever For Its Consumer Healthcare Business, Opts to Spin-off The Unit
07:17pm, Saturday, 15'th Jan 2022 Benzinga
GlaxoSmithKline rejects three purchase offers from Unilever for its Consumer Healthcare business. The U.K. pharma giant says the business is well-positioned to sustainably grow ahead of its categories in the years to come. GSK plans to create a new independent consumer company, which is on track to be achieved by mid-2022. U.K. pharma giant GlaxoSmithKline plc (NYSE: GSK ) has spurned multiple offers for its Consumer Healthcare business on the grounds that the offers undervalued the unit. GlaxoSmithKline said in a statement Saturday that Unilever plc (NYSE: UL ) tabled three unsolicited, conditional and non-binding proposals for acquiring its Consumer Healthcare Full story available on Benzinga.com
GlaxoSmithKline rejected $68B bid from Unilever for its consumer (NYSE:GSK)
06:46pm, Saturday, 15'th Jan 2022 Seeking Alpha
GlaxoSmithKline (GSK) said it rejected three non-binding offers from Unilever Plc (UL) for its consumer healthcare business, including its latest bid of 50B pounds ("$68B") in cash
GSK rejects $68b Unilever bid for consumer healthcare unit
06:39pm, Saturday, 15'th Jan 2022 ABC News
The pharmaceutical giant GlaxoSmithKline says it has rejected an unsolicited 50 billion-pound ($68.4 billion) bid from Unilever for its consumer healthcare goods unit
